ScoreWhy is Cabio Biotech (Wuhan) Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.50% and Operating profit at 10.26% over the last 5 years
- INTEREST(HY) At CNY 0.99 MM has Grown at 389.7%
- INTEREST COVERAGE RATIO(Q) Lowest at 6,043.31
- PRE-TAX PROFIT(Q) At CNY 25.37 MM has Fallen at -46%
2
With ROE of 10.11%, it has a fair valuation with a 2.68 Price to Book Value
- Over the past year, while the stock has generated a return of -18.68%, its profits have risen by 36.5% ; the PEG ratio of the company is 0.7
- At the current price, the company has a high dividend yield of 0.8
3
Below par performance in long term as well as near term
- Along with generating -18.68% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Cabio Biotech (Wuhan) Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Cabio Biotech (Wuhan) Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Cabio Biotech (Wuhan) Co., Ltd.
-30.65%
0.77
45.54%
China Shanghai Composite
13.33%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.50%
EBIT Growth (5y)
10.26%
EBIT to Interest (avg)
86.76
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.33
Tax Ratio
13.92%
Dividend Payout Ratio
27.15%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.13%
ROE (avg)
7.71%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
2.68
EV to EBIT
26.17
EV to EBITDA
18.98
EV to Capital Employed
2.92
EV to Sales
6.97
PEG Ratio
0.73
Dividend Yield
0.78%
ROCE (Latest)
11.17%
ROE (Latest)
10.11%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 245.65 MM
ROCE(HY)
Highest at 10.76%
RAW MATERIAL COST(Y)
Fallen by -40.99% (YoY
NET PROFIT(9M)
Higher at CNY 133.58 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 2.09 times
-21What is not working for the Company
INTEREST(HY)
At CNY 0.99 MM has Grown at 389.7%
INTEREST COVERAGE RATIO(Q)
Lowest at 6,043.31
PRE-TAX PROFIT(Q)
At CNY 25.37 MM has Fallen at -46%
NET PROFIT(Q)
At CNY 21.77 MM has Fallen at -48.34%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.98 times
NET SALES(Q)
Lowest at CNY 121.3 MM
OPERATING PROFIT(Q)
Lowest at CNY 22.31 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 18.39 %
Here's what is working for Cabio Biotech (Wuhan) Co., Ltd.
Operating Cash Flow
Highest at CNY 245.65 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Debtors Turnover Ratio
Highest at 2.09 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -40.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cabio Biotech (Wuhan) Co., Ltd.
Interest
At CNY 0.99 MM has Grown at 389.7%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 121.3 MM has Fallen at -19.34%
over average net sales of the previous four periods of CNY 150.37 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Interest Coverage Ratio
Lowest at 6,043.31
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Pre-Tax Profit
At CNY 25.37 MM has Fallen at -46%
over average net sales of the previous four periods of CNY 46.98 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 21.77 MM has Fallen at -48.34%
over average net sales of the previous four periods of CNY 42.14 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
Lowest at CNY 121.3 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY 22.31 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 18.39 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 1.98 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
